TURKU, FINLAND / ACCESSWIRE / August 26, 2015 / Medicortex Finland Oy has established a new diagnostic division/arm to its core business with the goal of developing a biomarker diagnostic test that ...
TURKU, Finland & STOCKHOLM--(BUSINESS WIRE)--Medicortex Finland Oy (www.medicortex.fi) and Dividend Sweden AB (www.dividendsweden.se) announced signing an agreement whereby Dividend will invest in ...
TURKU, Finland--(BUSINESS WIRE)--Medicortex Finland Oy, a Finnish biotechnology company focusing on brain injury diagnostics and drug development, announces receiving funding from the Finnish ...
Medicortex Finland Plc, a biopharmaceutical company focusing on the development of diagnostics and drug for mild traumatic brain injury (TBI), was granted a Finnish patent for detection of tissue ...
Medicortex Finland Oyj (“Medicortex”), together with its majority shareholders, has signed a binding SPA with Nosium Ab (publ) (“Nosium”), marking a significant step toward advancing the ...
Medicortex Finland Oy, a biotechnology company developing diagnostic tests for brain injury, announces successful closing of a pre-IPO share issue round that will allow the company to proceed to the ...
Medicortex Finland Oy is a start-up pharmaceutical company focused on the treatment of neurodegenerative conditions. The company is developing a pharmaceutical therapy, which will limit the long-term ...
On November 22, Y Science hosted a Life Science Pitching competition for early-stage startups and pre-startups. Today we had the opportunity to interview Dr. Begum Utz from Medicortex, the startup who ...
Medicortex Finland Oy (www.medicortex.fi), today announced the award of a 1.1 million dollars grant from the USA Department of Defense. The grant provides funding for continued clinical development of ...
Medicortex Finland Oy (www.medicortex.fi) and Dividend Sweden AB (www.dividendsweden.se) announced signing an agreement whereby Dividend will invest in Medicortex as a part of a pre-IPO round ...
TURKU, Finland--(BUSINESS WIRE)--Medicortex Finland Oy, a Finnish biotechnology company focusing on brain injury diagnostics and drug development, announces receiving funding from the Finnish ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results